Characterization and Drugs Screening in Human Dermal Fibroblasts Derived From Patient With Amiotrophic Lateral Sclerosis by Suárez, Alejandra & Sánchez Alcázar, José Antonio
Biosaia (revista de los másteres de Biotecnología Sanitaria y Biotecnología Ambiental, Industrial y Alimentaria de la UPO) nº8 (March, 2019) 
http://www.bioinfocabd.upo.es/biosaia/  @Biosaia 1 
Poster 
Characterization and Drugs Screening in Human 
Dermal Fibroblasts Derived From Patient With 
Amiotrophic Lateral Sclerosis 
Sánchez, J. A. (1); Suárez, A.(1,*) 
(1) Departamento de Fisiología, Anatomía y Biología Celular. Centro Andaluz de Biología del Desarrollo (CABD), 
Carretera de Utrera Km 1 41013 Sevilla 
 
Keywords: Amiotrophic Lateral Sclerosis; Human Dermal Fibroblast; Iron Accumulation. 
 
 
ABSTRACT 
Motivation: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by the loss of motor neurons. Though 
currently we unknow its etiology, there are several alterations related to its physiopathology, such as mutation in Superoxide 
dismutase-1 (SOD-1), an enzyme which prevents free radical production, and intracellular non-avaliable iron accumulation, 
both alterations have been observed in the patient. The mutated form of this enzyme tends to form fibrillar aggregates on the 
cytoplasm. In this way, the research line have two parts: the molecular characterization of the disease, and the elimination or 
reduction of  intracellular iron accumulation and the reestablishment of modified protein levels. Treatments screening allows to 
increase patient's survival due to we use commercialized compounds, with this approximation we can skip long proccess of 
drugs commercialization. 
Methods: Human Dermal Fibroblast (HDF) primary cultures with and without pathological background are used. Iron 
accumulation in this cultures is observed by Prussian Blue technique. Expression protein levels are measured by Western 
Blotting, TransferBlot, InmmunoBlot and ChemicDoc developing. Quantifications were calculated with ImageJ software. 
Preliminar Results: We observed differences in the expression protein levels involved in autophagy proccess (P62, LC3B), 
antioxidative activity (GPX, SOD1), lipid peroxidation (PLA2G6) and lisosomal dynamic (LAMP1). Drugs screening allowed to 
select several drugs which reduced intracellular iron levels. With this technique we did another screening combining that drugs 
to select the best combination. 
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